Sage Journals: Discover world-class research

Retricted access

Research article

First published 2015-3

Nonparametric Estimation of Maximum Tolerated Dose (MTD) In The Context of Phase I Clinical Trials

Anup Dewanji, Gopal K. Basak, Atanu Biswas

Calcutta Statistical Association Bulletin

Free access

Research article

First published 2001-11

Defining a tolerable concentration of methanol in alcoholic drinks

A J Paine, A D Dayan

Human & Experimental Toxicology

Retricted access

Other

First published 2002-10

An Investigation of the Traditional Algorithm-Based Designs for Phase 1 Cancer Clinical Trials

Seung-Ho Kang, Chul W. Ahn

Therapeutic Innovation & Regulatory Science

Free access

Research article

First published 2015-7

Regulatory Forum Commentary* Counterpoint

Jarig Darbes, Frank D. Sistare, Joseph J. DeGeorge

Toxicologic Pathology

Retricted access

Other

First published 2002-7

Phase 1 Oncology Clinical Trials for Related Subpopulations: The Power Walk Design *

Georgene Schroeder, Jeff A. Sloan, Stephen Cha [...]

Therapeutic Innovation & Regulatory Science

Free access

Research article

First published 2016-1

Regulatory Forum Opinion Piece*

Madhav G. Paranjpe, Melissa D. Denton, Tom J. Vidmar [...]

Toxicologic Pathology

Retricted access

Research article

First published 2014-9

Exploring Ethnic Differences in Toxicity in Early-Phase Clinical Trials for Oncology Drugs

Takashi Ogura, Satoshi Morita, Kan Yonemori [...]

Therapeutic Innovation & Regulatory Science

Free access

Research article

First published 1995-02

A Systemic Exposure-Based Alternative to the Maximum Tolerated Dose for Carcinogenicity Studies of Human Therapeutics

Joseph F. Contrera, Abigail C. Jacobs, Hullahalli R. Prasanna [...]

International Journal of Toxicology

Retricted access

Research article

First published 2014-3

A Continual Reassessment Method With Cohort Size Adaptation Based on Bayesian Posterior Probabilities in Phase I Dose-Finding Studies

Tomoyuki Kakizume, Satoshi Morita

Therapeutic Innovation & Regulatory Science

Free access

Research article

First published 2015-7

Regulatory Forum Commentary* Counterpoint

Prashant R. Nambiar, Daniel Morton

Toxicologic Pathology

Search results